{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T01:57:52Z","timestamp":1794535072128,"version":"4.9.1"},"reference-count":191,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T00:00:00Z","timestamp":1761004800000},"content-version":"vor","delay-in-days":20,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.pnpbp.2025.111533","type":"journal-article","created":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T15:05:41Z","timestamp":1761059141000},"page":"111533","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Changing your mind: neuroplastic mechanisms underlying the therapeutic effect of psychedelics in depression, PTSD, and addiction"],"prefix":"10.1016","volume":"142","author":[{"given":"Marta","family":"Palhas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R\u00e9mi","family":"Corne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raymond","family":"Mongeau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.pnpbp.2025.111533_bb0005","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.biopsych.2009.08.038","article-title":"Safety and efficacy of repeated-dose intravenous ketamine for treatment-resistant depression","volume":"67","author":"aan het Rot","year":"2010","journal-title":"Biol. Psychiatry"},{"issue":"5","key":"10.1016\/j.pnpbp.2025.111533_bb0010","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1007\/s00213-013-3304-5","article-title":"MDMA enhances hippocampal-dependent learning and memory under restrictive conditions, and modifies hippocampal spine density","volume":"231","author":"Abad","year":"2014","journal-title":"Psychopharmacology"},{"issue":"10","key":"10.1016\/j.pnpbp.2025.111533_bb0015","doi-asserted-by":"crossref","first-page":"7271","DOI":"10.1007\/s12035-015-9618-z","article-title":"Adaptive plasticity in the Hippocampus of Young mice intermittently exposed to MDMA could be the origin of memory deficits","volume":"53","author":"Abad","year":"2016","journal-title":"Mol. Neurobiol."},{"issue":"7845","key":"10.1016\/j.pnpbp.2025.111533_bb0020","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1038\/s41586-020-03047-0","article-title":"Antidepressant actions of ketamine engage cell-specific translation via eIF4E","volume":"590","author":"Aguilar-Valles","year":"2021","journal-title":"Nature"},{"issue":"11","key":"10.1016\/j.pnpbp.2025.111533_bb0025","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/j.tips.2021.08.003","article-title":"Neuroplasticity as a convergent mechanism of ketamine and classical psychedelics","volume":"42","author":"Aleksandrova","year":"2021","journal-title":"Trends Pharmacol. Sci."},{"issue":"3","key":"10.1016\/j.pnpbp.2025.111533_bb0030","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1111\/j.1369-1600.2010.00221.x","article-title":"Ecstasy (MDMA)-addicted subjects show increased serum levels of brain-derived neurotrophic factor, independently from a rise of drug-induced psychotic symptoms","volume":"15","author":"Angelucci","year":"2010","journal-title":"Addict. Biol."},{"issue":"1","key":"10.1016\/j.pnpbp.2025.111533_bb0035","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.bandc.2013.11.012","article-title":"BDNF serum levels in subjects developing or not post-traumatic stress disorder after trauma exposure","volume":"84","author":"Angelucci","year":"2014","journal-title":"Brain Cogn."},{"issue":"2","key":"10.1016\/j.pnpbp.2025.111533_bb0040","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/s12264-019-00422-4","article-title":"Ketamine alleviates fear generalization through GluN2B-BDNF signaling in mice","volume":"36","author":"Asim","year":"2020","journal-title":"Neurosci. Bull."},{"issue":"47","key":"10.1016\/j.pnpbp.2025.111533_bb0045","doi-asserted-by":"crossref","first-page":"19250","DOI":"10.1074\/jbc.M117.797092","article-title":"Pharmacochaperoning in a Drosophila model system rescues human dopamine transporter variants associated with infantile\/juvenile parkinsonism","volume":"292","author":"Asjad","year":"2017","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.pnpbp.2025.111533_bb0050","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1124\/pr.111.005108","article-title":"Brain-derived neurotrophic factor and neuropsychiatric disorders","volume":"64","author":"Autry","year":"2012","journal-title":"Pharmacol. Rev."},{"issue":"7354","key":"10.1016\/j.pnpbp.2025.111533_bb0055","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/nature10130","article-title":"NMDA receptor blockade at rest triggers rapid behavioural antidepressant responses","volume":"475","author":"Autry","year":"2011","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.pnpbp.2025.111533_bb0060","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1080\/00952990.2020.1808982","article-title":"Ketamine-facilitated behavioral treatment for cannabis use disorder: A proof of concept study","volume":"47","author":"Azhari","year":"2021","journal-title":"Am. J. Drug Alcohol Abuse"},{"issue":"Pt A","key":"10.1016\/j.pnpbp.2025.111533_bb0065","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.brainres.2014.10.058","article-title":"Brain-derived neurotrophic factor and addiction: pathological versus therapeutic effects on drug seeking","volume":"1628","author":"Barker","year":"2015","journal-title":"Brain Res."},{"issue":"4","key":"10.1016\/j.pnpbp.2025.111533_bb0070","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1177\/2045125314527985","article-title":"Classical hallucinogens as antidepressants? A review of pharmacodynamics and putative clinical roles","volume":"4","author":"Baumeister","year":"2014","journal-title":"Ther. Adv. Psychopharmacol."},{"issue":"23","key":"10.1016\/j.pnpbp.2025.111533_bb0075","doi-asserted-by":"crossref","first-page":"9870","DOI":"10.1073\/pnas.0700436104","article-title":"Mechanism of the 5-hydroxytryptamine 2A receptor-mediated facilitation of synaptic activity in prefrontal cortex","volume":"104","author":"B\u00e9\u00efque","year":"2007","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"4","key":"10.1016\/j.pnpbp.2025.111533_bb0080","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1111\/j.1476-5381.1996.tb15253.x","article-title":"Neurochemical and behavioural interactions between ibogaine and nicotine in the rat","volume":"117","author":"Benwell","year":"1996","journal-title":"Br. J. Pharmacol."},{"issue":"4","key":"10.1016\/j.pnpbp.2025.111533_bb0085","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S0006-3223(99)00230-9","article-title":"Antidepressant effects of ketamine in depressed patients","volume":"47","author":"Berman","year":"2000","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.pnpbp.2025.111533_bb0090","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.neuropharm.2015.10.034","article-title":"BDNF - a key transducer of antidepressant effects","volume":"102","author":"Bj\u00f6rkholm","year":"2016","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pnpbp.2025.111533_bb0095","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.pnpbp.2015.03.002","article-title":"Classic hallucinogens in the treatment of addictions","volume":"64","author":"Bogenschutz","year":"2016","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"issue":"12","key":"10.1016\/j.pnpbp.2025.111533_bb0100","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1007\/s40262-017-0540-6","article-title":"Pharmacokinetics of escalating doses of Oral psilocybin in healthy adults","volume":"56","author":"Brown","year":"2017","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.pnpbp.2025.111533_bb0105","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.neulet.2018.07.038","article-title":"PET imaging of synaptic density: A new tool for investigation of neuropsychiatric diseases","volume":"691","author":"Cai","year":"2019","journal-title":"Neurosci. Lett."},{"issue":"1","key":"10.1016\/j.pnpbp.2025.111533_bb0110","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1038\/s41386-022-01389-z","article-title":"Towards an understanding of psychedelic-induced neuroplasticity. Neuropsychopharmacology: official publication of the American college of","volume":"48","author":"Calder","year":"2023","journal-title":"Neuropsychopharmacology"},{"issue":"7","key":"10.1016\/j.pnpbp.2025.111533_bb0115","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1021\/acschemneuro.8b00134","article-title":"Effects of N, N-dimethyltryptamine on rat behaviors relevant to anxiety and depression","volume":"9","author":"Cameron","year":"2018","journal-title":"ACS Chem. Neurosci."},{"issue":"7842","key":"10.1016\/j.pnpbp.2025.111533_bb0120","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1038\/s41586-020-3008-z","article-title":"A non-hallucinogenic psychedelic analogue with therapeutic potential","volume":"589","author":"Cameron","year":"2021","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.pnpbp.2025.111533_bb0125","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1177\/0269881116677104","article-title":"The serotonin 5-HT2C receptor and the non-addictive nature of classic hallucinogens","volume":"31","author":"Canal","year":"2017","journal-title":"J. Psychopharmacol. (Oxford, England)"},{"issue":"6579","key":"10.1016\/j.pnpbp.2025.111533_bb0130","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1126\/science.abl8615","article-title":"Structure-based discovery of nonhallucinogenic psychedelic analogs","volume":"375","author":"Cao","year":"2022","journal-title":"Science (New York, N.Y.)"},{"issue":"7","key":"10.1016\/j.pnpbp.2025.111533_bb0135","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/S2215-0366(16)30065-7","article-title":"Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study","volume":"3","author":"Carhart-Harris","year":"2016","journal-title":"Lancet Psychiatry"},{"issue":"2","key":"10.1016\/j.pnpbp.2025.111533_bb0140","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1007\/s00213-017-4771-x","article-title":"Psilocybin with psychological support for treatment-resistant depression: six-month follow-up","volume":"235","author":"Carhart-Harris","year":"2018","journal-title":"Psychopharmacology"},{"issue":"9","key":"10.1016\/j.pnpbp.2025.111533_bb0145","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1038\/mp.2015.176","article-title":"Activation of a ventral hippocampus-medial prefrontal cortex pathway is both necessary and sufficient for an antidepressant response to ketamine","volume":"21","author":"Carreno","year":"2016","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.pnpbp.2025.111533_bb0150","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1007\/978-3-642-45106-5_17","article-title":"Neurotrophins and psychiatric disorders","volume":"220","author":"Castr\u00e9n","year":"2014","journal-title":"Handb. Exp. Pharmacol."},{"issue":"7","key":"10.1016\/j.pnpbp.2025.111533_bb0155","doi-asserted-by":"crossref","first-page":"963","DOI":"10.2174\/1570159X15666170221101054","article-title":"Beyond ketamine: new approaches to the development of safer antidepressants","volume":"15","author":"Chaki","year":"2017","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.pnpbp.2025.111533_bb0160","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.neuroscience.2021.04.013","article-title":"Insulin-like growth factors may be markers of both traumatic brain injury and fear-related stress","volume":"466","author":"Corne","year":"2021","journal-title":"Neuroscience"},{"issue":"4","key":"10.1016\/j.pnpbp.2025.111533_bb0165","first-page":"386","article-title":"Reduced neuronal size and glial cell density in area 9 of the dorsolateral prefrontal cortex in subjects with major depressive disorder","volume":"12","author":"Cotter","year":"2002","journal-title":"Cereb. Cortex (New York, N.Y.: 1991)"},{"key":"10.1016\/j.pnpbp.2025.111533_bb0170","author":"Cybin"},{"issue":"1","key":"10.1016\/j.pnpbp.2025.111533_bb0175","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.biopsych.2013.08.009","article-title":"The effects of subanesthetic ketamine infusions on motivation to quit and cue-induced craving in cocaine-dependent research volunteers","volume":"76","author":"Dakwar","year":"2014","journal-title":"Biol. Psychiatry"},{"issue":"1","key":"10.1016\/j.pnpbp.2025.111533_bb0180","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1038\/mp.2016.39","article-title":"Cocaine self-administration disrupted by the N-methyl-D-aspartate receptor antagonist ketamine: a randomized, crossover trial","volume":"22","author":"Dakwar","year":"2017","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.pnpbp.2025.111533_bb0185","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.neuropharm.2018.01.005","article-title":"A sub-set of psychoactive effects may be critical to the behavioral impact of ketamine on cocaine use disorder: results from a randomized, controlled laboratory study","volume":"142","author":"Dakwar","year":"2018","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pnpbp.2025.111533_bb0190","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.3389\/fpsyg.2019.01234","article-title":"Modulation of serum brain-derived neurotrophic factor by a single dose of Ayahuasca: observation from a randomized controlled trial","volume":"10","author":"de Almeida","year":"2019","journal-title":"Front. Psychol."},{"issue":"5","key":"10.1016\/j.pnpbp.2025.111533_bb0195","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1523\/JNEUROSCI.1659-20.2020","article-title":"Hallucinogens in mental health: preclinical and clinical studies on LSD, psilocybin, MDMA, and ketamine","volume":"41","author":"De Gregorio","year":"2021","journal-title":"J. Neurosci."},{"key":"10.1016\/j.pnpbp.2025.111533_bb0200","article-title":"Psychedelics and neuroplasticity: A systematic review unraveling the biological underpinnings of psychedelics","volume":"12","author":"de Vos","year":"2021","journal-title":"Front. Psychol."},{"issue":"5","key":"10.1016\/j.pnpbp.2025.111533_bb0205","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/j.pnpbp.2009.04.018","article-title":"Brain-derived neurotrophic factor plasma levels in patients suffering from post-traumatic stress disorder","volume":"33","author":"Dell'Osso","year":"2009","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"issue":"1","key":"10.1016\/j.pnpbp.2025.111533_bb0210","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1038\/s41398-022-01943-9","article-title":"IGF-1 release in the medial prefrontal cortex mediates the rapid and sustained antidepressant-like actions of ketamine","volume":"12","author":"Deyama","year":"2022","journal-title":"Transl. Psychiatry"},{"issue":"10","key":"10.1016\/j.pnpbp.2025.111533_bb0215","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1007\/s40262-017-0513-9","article-title":"Pharmacokinetics and pharmacodynamics of lysergic acid diethylamide in healthy subjects","volume":"56","author":"Dolder","year":"2017","journal-title":"Clin. Pharmacokinet."},{"issue":"Pt 1","key":"10.1016\/j.pnpbp.2025.111533_bb0220","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.brainresbull.2016.03.002","article-title":"Ayahuasca: pharmacology, neuroscience and therapeutic potential","volume":"126","author":"Dom\u00ednguez-Clav\u00e9","year":"2016","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.pnpbp.2025.111533_bb0225","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1186\/s13287-024-03909-8","article-title":"Psychedelic LSD activates neurotrophic signal but fails to stimulate neural stem cells","volume":"15","author":"Dong","year":"2024","journal-title":"Stem Cell Res Ther"},{"issue":"6103","key":"10.1016\/j.pnpbp.2025.111533_bb0230","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1126\/science.1222939","article-title":"Synaptic dysfunction in depression: potential therapeutic targets","volume":"338","author":"Duman","year":"2012","journal-title":"Science (New York, N.Y.)"},{"issue":"5","key":"10.1016\/j.pnpbp.2025.111533_bb0235","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/j.biopsych.2006.05.047","article-title":"A role for MAP kinase signaling in behavioral models of depression and antidepressant treatment","volume":"61","author":"Duman","year":"2007","journal-title":"Biol. Psychiatry"},{"issue":"10","key":"10.1016\/j.pnpbp.2025.111533_bb0240","doi-asserted-by":"crossref","first-page":"2408","DOI":"10.1021\/acschemneuro.8b00155","article-title":"Dark classics in chemical neuroscience: 3,4-Methylenedioxymethamphetamine","volume":"9","author":"Dunlap","year":"2018","journal-title":"ACS Chem. Neurosci."},{"issue":"4","key":"10.1016\/j.pnpbp.2025.111533_bb0245","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1007\/s12031-014-0399-z","article-title":"A study on the mechanism by which MDMA protects against dopaminergic dysfunction after minimal traumatic brain injury (mTBI) in mice","volume":"54","author":"Edut","year":"2014","journal-title":"J. Mol. Neurosci."},{"issue":"2","key":"10.1016\/j.pnpbp.2025.111533_bb0250","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s11011-007-9048-3","article-title":"Early maternal separation alters the response to traumatization: resulting in increased levels of hippocampal neurotrophic factors","volume":"22","author":"Faure","year":"2007","journal-title":"Metab. Brain Dis."},{"issue":"6","key":"10.1016\/j.pnpbp.2025.111533_bb0255","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1001\/jamapsychiatry.2014.62","article-title":"Efficacy of intravenous ketamine for treatment of chronic posttraumatic stress disorder: a randomized clinical trial","volume":"71","author":"Feder","year":"2014","journal-title":"JAMA Psychiatry"},{"issue":"2","key":"10.1016\/j.pnpbp.2025.111533_bb0260","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1176\/appi.ajp.2020.20050596","article-title":"A randomized controlled trial of repeated ketamine administration for chronic posttraumatic stress disorder","volume":"178","author":"Feder","year":"2021","journal-title":"Am. J. Psychiatry"},{"issue":"Pt A","key":"10.1016\/j.pnpbp.2025.111533_bb0265","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.pnpbp.2018.03.003","article-title":"MDMA-assisted psychotherapy for PTSD: are memory reconsolidation and fear extinction underlying mechanisms?","volume":"84","author":"Feduccia","year":"2018","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"issue":"4","key":"10.1016\/j.pnpbp.2025.111533_bb0270","doi-asserted-by":"crossref","first-page":"2182","DOI":"10.1038\/s41380-022-01442-9","article-title":"Insulin-like growth factor I mitigates post-traumatic stress by inhibiting AMP-kinase in orexin neurons","volume":"27","author":"Fern\u00e1ndez de Sevilla","year":"2022","journal-title":"Mol. Psychiatry"},{"issue":"1","key":"10.1016\/j.pnpbp.2025.111533_bb0275","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.pnpbp.2008.10.005","article-title":"Reduced levels of NR2A and NR2B subunits of NMDA receptor and PSD-95 in the prefrontal cortex in major depression","volume":"33","author":"Feyissa","year":"2009","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"issue":"4","key":"10.1016\/j.pnpbp.2025.111533_bb0280","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/nrn.2018.16","article-title":"Dendritic structural plasticity and neuropsychiatric disease","volume":"19","author":"Forrest","year":"2018","journal-title":"Nat. Rev. Neurosci."},{"issue":"9","key":"10.1016\/j.pnpbp.2025.111533_bb0285","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1111\/j.1360-0443.2006.01511.x","article-title":"The origin of MDMA (ecstasy) revisited: the true story reconstructed from the original documents","volume":"101","author":"Freudenmann","year":"2006","journal-title":"Addiction"},{"issue":"10","key":"10.1016\/j.pnpbp.2025.111533_bb0290","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1038\/s41386-020-0705-0","article-title":"Medial PFC AMPA receptor and BDNF signaling are required for the rapid and sustained antidepressant-like effects of 5-HT1A receptor stimulation. Neuropsychopharmacology: official publication of the American college of","volume":"45","author":"Fukumoto","year":"2020","journal-title":"Neuropsychopharmacology"},{"issue":"1","key":"10.1016\/j.pnpbp.2025.111533_bb0295","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.pnpbp.2007.07.027","article-title":"Acute administration of ketamine induces antidepressant-like effects in the forced swimming test and increases BDNF levels in the rat hippocampus","volume":"32","author":"Garcia","year":"2008","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"issue":"3","key":"10.1016\/j.pnpbp.2025.111533_bb0300","doi-asserted-by":"crossref","first-page":"157","DOI":"10.2174\/1874473708666150107121331","article-title":"Psilocybin-occasioned mystical experiences in the treatment of tobacco addiction","volume":"7","author":"Garcia-Romeu","year":"2014","journal-title":"Curr. Drug Abuse Rev."},{"issue":"2","key":"10.1016\/j.pnpbp.2025.111533_bb0305","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/S0091-3057(02)00844-4","article-title":"Modulation of DOI-induced increases in cortical BDNF expression by group II mGlu receptors","volume":"73","author":"Gewirtz","year":"2002","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"6","key":"10.1016\/j.pnpbp.2025.111533_bb0310","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1177\/1073858417697037","article-title":"Neurotrophins and Proneurotrophins: focus on synaptic activity and plasticity in the brain","volume":"23","author":"Gibon","year":"2017","journal-title":"Neuroscientist"},{"issue":"1","key":"10.1016\/j.pnpbp.2025.111533_bb0315","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1001\/archpsyc.57.1.65","article-title":"Decreased dendritic spine density on prefrontal cortical pyramidal neurons in schizophrenia","volume":"57","author":"Glantz","year":"2000","journal-title":"Arch. Gen. Psychiatry"},{"issue":"4","key":"10.1016\/j.pnpbp.2025.111533_bb0320","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1021\/jm00082a014","article-title":"Binding of phenylalkylamine derivatives at 5-HT1C and 5-HT2 serotonin receptors: evidence for a lack of selectivity","volume":"35","author":"Glennon","year":"1992","journal-title":"J. Med. Chem."},{"issue":"2","key":"10.1016\/j.pnpbp.2025.111533_bb0325","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/S0006-8993(96)01414-X","article-title":"Evidence for roles of kappa-opioid and NMDA receptors in the mechanism of action of ibogaine","volume":"749","author":"Glick","year":"1997","journal-title":"Brain Res."},{"key":"10.1016\/j.pnpbp.2025.111533_bb0330","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1111\/j.1749-6632.2000.tb05211.x","article-title":"18-Methoxycoronaridine (18-MC) and ibogaine: comparison of antiaddictive efficacy, toxicity, and mechanisms of action","volume":"914","author":"Glick","year":"2000","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.pnpbp.2025.111533_bb0335","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0099-9598(01)56006-X","article-title":"Mechanisms of action of ibogaine: relevance to putative therapeutic effects and development of a safer iboga alkaloid congener","volume":"56","author":"Glick","year":"2001","journal-title":"Alkaloids Chem. Biol."},{"issue":"3","key":"10.1016\/j.pnpbp.2025.111533_bb0340","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.biopsych.2009.08.026","article-title":"Functional and dysfunctional synaptic plasticity in prefrontal cortex: roles in psychiatric disorders","volume":"67","author":"Goto","year":"2010","journal-title":"Biol. Psychiatry"},{"issue":"3","key":"10.1016\/j.pnpbp.2025.111533_bb0345","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1124\/pr.55.3.3","article-title":"The pharmacology and clinical pharmacology of 3,4-methylenedioxymethamphetamine (MDMA, \u201cecstasy\u201d)","volume":"55","author":"Green","year":"2003","journal-title":"Pharmacol. Rev."},{"issue":"1","key":"10.1016\/j.pnpbp.2025.111533_bb0350","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1001\/archgenpsychiatry.2010.116","article-title":"Pilot study of psilocybin treatment for anxiety in patients with advanced-stage cancer","volume":"68","author":"Grob","year":"2011","journal-title":"Arch. Gen. Psychiatry"},{"issue":"2","key":"10.1016\/j.pnpbp.2025.111533_bb0355","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.pbb.2007.10.003","article-title":"Actions of 3,4-methylenedioxymethamphetamine (MDMA) on cerebral dopaminergic, serotonergic and cholinergic neurons","volume":"90","author":"Gudelsky","year":"2008","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"6","key":"10.1016\/j.pnpbp.2025.111533_bb0360","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/S1734-1140(10)70361-3","article-title":"Chronic ecstasy use increases neurotrophin-4 gene expression and protein levels in the rat brain","volume":"62","author":"Hatami","year":"2010","journal-title":"Pharmacol. Rep."},{"issue":"3","key":"10.1016\/j.pnpbp.2025.111533_bb0365","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.pnpbp.2010.01.010","article-title":"Serum brain-derived neurotrophic factor in patients with trauma psychopathology","volume":"34","author":"Hauck","year":"2010","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"issue":"13","key":"10.1016\/j.pnpbp.2025.111533_bb0370","doi-asserted-by":"crossref","first-page":"2420","DOI":"10.1096\/fj.06-6394fje","article-title":"Autoregulation of glial cell line-derived neurotrophic factor expression: implications for the long-lasting actions of the anti-addiction drug, Ibogaine","volume":"20","author":"He","year":"2006","journal-title":"FASEB J."},{"issue":"3","key":"10.1016\/j.pnpbp.2025.111533_bb0375","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1523\/JNEUROSCI.3959-04.2005","article-title":"Glial cell line-derived neurotrophic factor mediates the desirable actions of the anti-addiction drug ibogaine against alcohol consumption","volume":"25","author":"He","year":"2005","journal-title":"J. Neurosci."},{"key":"10.1016\/j.pnpbp.2025.111533_bb0380","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.jad.2021.03.073","article-title":"Real-world evidence from a European cohort study of patients with treatment resistant depression: treatment patterns and clinical outcomes","volume":"290","author":"Heerlein","year":"2021","journal-title":"J. Affect. Disord."},{"issue":"11","key":"10.1016\/j.pnpbp.2025.111533_bb0385","doi-asserted-by":"crossref","first-page":"2459","DOI":"10.1002\/cne.23048","article-title":"(\u00b1)3,4-methylenedioxymethamphetamine (\u201cecstasy\u201d) treatment modulates expression of neurotrophins and their receptors in multiple regions of adult rat brain","volume":"520","author":"Hemmerle","year":"2012","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.pnpbp.2025.111533_bb0390","series-title":"Neuropathology of Drug Addictions and Substance Misuse","first-page":"893","article-title":"Chapter 88 - novel drugs of abuse: Cannabinoids, stimulants, and hallucinogens","author":"Herrmann","year":"2016"},{"issue":"17","key":"10.1016\/j.pnpbp.2025.111533_bb0395","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2022489118","article-title":"Harnessing psilocybin: antidepressant-like behavioral and synaptic actions of psilocybin are independent of 5-HT2R activation in mice","volume":"118","author":"Hesselgrave","year":"2021","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"6","key":"10.1016\/j.pnpbp.2025.111533_bb0400","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1021\/acschemneuro.9b00493","article-title":"Psychedelics, but not ketamine, produce persistent antidepressant-like effects in a rodent experimental system for the study of depression","volume":"11","author":"Hibicke","year":"2020","journal-title":"ACS Chem. Neurosci."},{"issue":"1\u20132","key":"10.1016\/j.pnpbp.2025.111533_bb0405","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1080\/02791072.1979.10472092","article-title":"How LSD originated","volume":"11","author":"Hofmann","year":"1979","journal-title":"J. Psychedelic Drugs"},{"issue":"36","key":"10.1016\/j.pnpbp.2025.111533_bb0410","doi-asserted-by":"crossref","first-page":"9490","DOI":"10.1523\/JNEUROSCI.1743-16.2016","article-title":"Increasing the GluN2A\/GluN2B ratio in neurons of the mouse basal and lateral amygdala inhibits the modification of an existing fear memory trace","volume":"36","author":"Holehonnur","year":"2016","journal-title":"J. Neurosci."},{"issue":"3","key":"10.1016\/j.pnpbp.2025.111533_bb0415","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1038\/s41386-019-0569-3","article-title":"Distinct acute effects of LSD, MDMA, and D-amphetamine in healthy subjects","volume":"45","author":"Holze","year":"2020","journal-title":"Neuropsychopharmacology"},{"issue":"1\u20133","key":"10.1016\/j.pnpbp.2025.111533_bb0420","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.ejphar.2010.10.094","article-title":"5-HT(2A) and 5-HT(2C) receptor stimulation are differentially involved in the cortical dopamine efflux-studied in 5-HT(2A) and 5-HT(2C) genetic mutant mice","volume":"652","author":"Huang","year":"2011","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.pnpbp.2025.111533_bb0425","first-page":"1076459","article-title":"Serotonergic psychedelics for depression: what do we know about neurobiological mechanisms of action?","volume":"13","author":"Husain","year":"2023","journal-title":"Front. Psychol."},{"issue":"2","key":"10.1016\/j.pnpbp.2025.111533_bb0430","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1021\/acsptsci.0c00099","article-title":"Low doses of LSD acutely increase BDNF blood plasma levels in healthy volunteers","volume":"4","author":"Hutten","year":"2020","journal-title":"ACS Pharmacol. Transl. Sci."},{"issue":"2","key":"10.1016\/j.pnpbp.2025.111533_bb0435","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1039\/D0NP00033G","article-title":"The iboga enigma: the chemistry and neuropharmacology of iboga alkaloids and related analogs","volume":"38","author":"Iyer","year":"2021","journal-title":"Nat. Prod. Rep."},{"issue":"7","key":"10.1016\/j.pnpbp.2025.111533_bb0440","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1016\/j.pnpbp.2011.05.010","article-title":"The mTOR signaling pathway in the prefrontal cortex is compromised in major depressive disorder","volume":"35","author":"Jernigan","year":"2011","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"issue":"2","key":"10.1016\/j.pnpbp.2025.111533_bb0445","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.neulet.2008.06.028","article-title":"5-HT2A\/2C receptor blockade regulates progenitor cell proliferation in the adult rat hippocampus","volume":"441","author":"Jha","year":"2008","journal-title":"Neurosci. Lett."},{"issue":"2","key":"10.1016\/j.pnpbp.2025.111533_bb0455","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/j.neuropharm.2011.02.023","article-title":"Impaired safety signal learning may be a biomarker of PTSD","volume":"62","author":"Jovanovic","year":"2012","journal-title":"Neuropharmacology"},{"issue":"1","key":"10.1016\/j.pnpbp.2025.111533_bb0460","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1093\/ijnp\/pyaa087","article-title":"Ketamine and serotonergic psychedelics: common mechanisms underlying the effects of rapid-acting antidepressants","volume":"24","author":"Kadriu","year":"2021","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.pnpbp.2025.111533_bb0465","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.neubiorev.2015.08.016","article-title":"The prosocial effects of 3,4-methylenedioxymethamphetamine (MDMA): controlled studies in humans and laboratory animals","volume":"57","author":"Kamilar-Britt","year":"2015","journal-title":"Neurosci. Biobehav. Rev."},{"issue":"9","key":"10.1016\/j.pnpbp.2025.111533_bb0470","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1038\/nm.2886","article-title":"Decreased expression of synapse-related genes and loss of synapses in major depressive disorder","volume":"18","author":"Kang","year":"2012","journal-title":"Nat. Med."},{"key":"10.1016\/j.pnpbp.2025.111533_bb0475","article-title":"The mechanisms behind rapid antidepressant effects of ketamine: A systematic review with a focus on molecular neuroplasticity","volume":"13","author":"Kang","year":"2022","journal-title":"Front. Psychol."},{"issue":"7932","key":"10.1016\/j.pnpbp.2025.111533_bb0480","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1038\/s41586-022-05258-z","article-title":"Bespoke library docking for 5-HT2A receptor agonists with antidepressant activity","volume":"610","author":"Kaplan","year":"2022","journal-title":"Nature"},{"issue":"8","key":"10.1016\/j.pnpbp.2025.111533_bb0485","doi-asserted-by":"crossref","first-page":"6939","DOI":"10.1007\/s12035-018-0885-3","article-title":"Drug targets in Neurotrophin signaling in the central and peripheral nervous system","volume":"55","author":"Kashyap","year":"2018","journal-title":"Mol. Neurobiol."},{"issue":"2","key":"10.1016\/j.pnpbp.2025.111533_bb0490","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1192\/bjp.bp.108.052688","article-title":"Morphometric analysis of neuronal and glial cell pathology in the dorsolateral prefrontal cortex in late-life depression","volume":"195","author":"Khundakar","year":"2009","journal-title":"Br. J. Psychiatry J. Ment. Sci."},{"issue":"8","key":"10.1016\/j.pnpbp.2025.111533_bb0495","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1038\/s41593-021-00868-8","article-title":"Sustained effects of rapidly acting antidepressants require BDNF-dependent MeCP2 phosphorylation","volume":"24","author":"Kim","year":"2021","journal-title":"Nat. Neurosci."},{"issue":"3","key":"10.1016\/j.pnpbp.2025.111533_bb0500","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/j.neuroscience.2010.05.054","article-title":"Changes in 5-HT2A-mediated behavior and 5-HT2A- and 5-HT1A receptor binding and expression in conditional brain-derived neurotrophic factor knock-out mice","volume":"169","author":"Klein","year":"2010","journal-title":"Neuroscience"},{"key":"10.1016\/j.pnpbp.2025.111533_bb0505","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbr.2020.112548","article-title":"Overlap in the neural circuitry and molecular mechanisms underlying ketamine abuse and its use as an antidepressant","volume":"384","author":"Kokane","year":"2020","journal-title":"Behav. Brain Res."},{"issue":"8","key":"10.1016\/j.pnpbp.2025.111533_bb0510","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.biopsych.2014.04.010","article-title":"Psilocybin-induced decrease in amygdala reactivity correlates with enhanced positive mood in healthy volunteers","volume":"78","author":"Kraehenmann","year":"2015","journal-title":"Biol. Psychiatry"},{"issue":"7","key":"10.1016\/j.pnpbp.2025.111533_bb0515","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1177\/0269881112439253","article-title":"Lysergic acid diethylamide (LSD) for alcoholism: meta-analysis of randomized controlled trials","volume":"26","author":"Krebs","year":"2012","journal-title":"J. Psychopharmacol. (Oxford, England)"},{"issue":"6","key":"10.1016\/j.pnpbp.2025.111533_bb0520","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1093\/ijnp\/pyaa018","article-title":"Reviewing the potential of psychedelics for the treatment of PTSD","volume":"23","author":"Krediet","year":"2020","journal-title":"Int. J. Neuropsychopharmacol."},{"issue":"4","key":"10.1016\/j.pnpbp.2025.111533_bb0525","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/S0740-5472(02)00275-1","article-title":"Ketamine psychotherapy for heroin addiction: immediate effects and two-year follow-up","volume":"23","author":"Krupitsky","year":"2002","journal-title":"J. Subst. Abus. Treat."},{"issue":"1","key":"10.1016\/j.pnpbp.2025.111533_bb0530","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1080\/02791072.2007.10399860","article-title":"Single versus repeated sessions of ketamine-assisted psychotherapy for people with heroin dependence","volume":"39","author":"Krupitsky","year":"2007","journal-title":"J. Psychoactive Drugs"},{"issue":"12","key":"10.1016\/j.pnpbp.2025.111533_bb0535","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1016\/j.biopsych.2013.03.026","article-title":"Rapid-acting glutamatergic antidepressants: the path to ketamine and beyond","volume":"73","author":"Krystal","year":"2013","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.pnpbp.2025.111533_bb0540","article-title":"Study protocol for \u201cMDMA-assisted therapy as a treatment for major depressive disorder: A proof of principle study\u201d","volume":"13","author":"Kvam","year":"2022","journal-title":"Front. Psychol."},{"issue":"1","key":"10.1016\/j.pnpbp.2025.111533_bb0545","doi-asserted-by":"crossref","first-page":"pyu033","DOI":"10.1093\/ijnp\/pyu033","article-title":"BDNF release is required for the behavioral actions of ketamine","volume":"18","author":"Lepack","year":"2014","journal-title":"Int. J. Neuropsychopharmacol."},{"issue":"5994","key":"10.1016\/j.pnpbp.2025.111533_bb0550","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1126\/science.1190287","article-title":"mTOR-dependent synapse formation underlies the rapid antidepressant effects of NMDA antagonists","volume":"329","author":"Li","year":"2010","journal-title":"Science (New York, N.Y.)"},{"key":"10.1016\/j.pnpbp.2025.111533_bb0555","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.3389\/fphar.2019.01702","article-title":"Ketamine alleviates postoperative depression-like symptoms in susceptible mice: the role of BDNF-TrkB signaling","volume":"10","author":"Li","year":"2020","journal-title":"Front. Pharmacol."},{"issue":"5111","key":"10.1016\/j.pnpbp.2025.111533_bb0560","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1126\/science.8493557","article-title":"GDNF: a glial cell line-derived neurotrophic factor for midbrain dopaminergic neurons","volume":"260","author":"Lin","year":"1993","journal-title":"Science (New York, N.Y.)"},{"issue":"4","key":"10.1016\/j.pnpbp.2025.111533_bb0565","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1176\/appi.ajp.2011.10121780","article-title":"Resting amygdala and medial prefrontal metabolism predicts functional activation of the fear extinction circuit","volume":"169","author":"Linnman","year":"2012","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.pnpbp.2025.111533_bb0570","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7573\/dic.212305","article-title":"Ketamine as treatment for post-traumatic stress disorder: a review","volume":"8","author":"Liriano","year":"2019","journal-title":"Drugs Context"},{"issue":"11","key":"10.1016\/j.pnpbp.2025.111533_bb0575","doi-asserted-by":"crossref","first-page":"3170","DOI":"10.1016\/j.celrep.2018.05.022","article-title":"Psychedelics promote structural and functional neural plasticity","volume":"23","author":"Ly","year":"2018","journal-title":"Cell Rep."},{"issue":"1","key":"10.1016\/j.pnpbp.2025.111533_bb0580","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1038\/s41467-017-01709-8","article-title":"TrkB dependent adult hippocampal progenitor differentiation mediates sustained ketamine antidepressant response","volume":"8","author":"Ma","year":"2017","journal-title":"Nat. Commun."},{"issue":"12","key":"10.1016\/j.pnpbp.2025.111533_bb0585","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.4088\/JCP.08m04659","article-title":"Brain-derived neurotrophic factor and initial antidepressant response to an N-methyl-D-aspartate antagonist","volume":"70","author":"Machado-Vieira","year":"2009","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.pnpbp.2025.111533_bb0590","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.pneurobio.2015.12.001","article-title":"New targets for rapid antidepressant action","volume":"152","author":"Machado-Vieira","year":"2017","journal-title":"Prog. Neurobiol."},{"issue":"6","key":"10.1016\/j.pnpbp.2025.111533_bb0595","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/j.eurpsy.2015.04.007","article-title":"The role of specific early trauma in adult depression: A meta-analysis of published literature. Childhood trauma and adult depression","volume":"30","author":"Mandelli","year":"2015","journal-title":"Eur. Psychiatry"},{"key":"10.1016\/j.pnpbp.2025.111533_bb0600","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/7854_2017_480","article-title":"Interactions of hallucinogens with the glutamatergic system: permissive network effects mediated through cortical layer V pyramidal neurons","volume":"36","author":"Marek","year":"2018","journal-title":"Curr. Top. Behav. Neurosci."},{"issue":"6","key":"10.1016\/j.pnpbp.2025.111533_bb0605","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1007\/s00702-017-1706-y","article-title":"The hallucinogen 2,5-dimethoxy-4-iodoamphetamine hydrochloride activates neurotrophin receptors in a neuronal cell line and promotes neurites extension","volume":"124","author":"Marinova","year":"2017","journal-title":"J. Neural Transm. (Vienna, Austria : 1996)"},{"issue":"3","key":"10.1016\/j.pnpbp.2025.111533_bb0610","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/s00213-005-2183-9","article-title":"Distinct temporal phases in the behavioral pharmacology of LSD: dopamine D2 receptor-mediated effects in the rat and implications for psychosis","volume":"180","author":"Marona-Lewicka","year":"2005","journal-title":"Psychopharmacology"},{"issue":"1\u20132","key":"10.1016\/j.pnpbp.2025.111533_bb0615","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.neulet.2006.03.055","article-title":"Differential effects of 3,4-methylenedioxymethamphetamine (MDMA, \"ecstasy\") on BDNF mRNA expression in rat frontal cortex and hippocampus","volume":"402","author":"Mart\u00ednez-Turrillas","year":"2006","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.pnpbp.2025.111533_bb0620","doi-asserted-by":"crossref","first-page":"193","DOI":"10.3389\/fphar.2019.00193","article-title":"Ibogaine administration modifies GDNF and BDNF expression in brain regions involved in Mesocorticolimbic and Nigral dopaminergic circuits","volume":"10","author":"Marton","year":"2019","journal-title":"Front. Pharmacol."},{"issue":"1","key":"10.1016\/j.pnpbp.2025.111533_bb0625","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/0304-3940(95)11608-Y","article-title":"Properties of ibogaine and its principal metabolite (12-hydroxyibogamine) at the MK-801 binding site of the NMDA receptor complex","volume":"192","author":"Mash","year":"1995","journal-title":"Neurosci. Lett."},{"issue":"2 Suppl","key":"10.1016\/j.pnpbp.2025.111533_bb0630","first-page":"S195","article-title":"The correlation between ketamine and posttraumatic stress disorder in burned service members","volume":"64","author":"McGhee","year":"2008","journal-title":"J. Trauma"},{"issue":"4","key":"10.1016\/j.pnpbp.2025.111533_bb0635","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1017\/S0033291714001603","article-title":"A systematic review and meta-analysis of randomized, double-blind, placebo-controlled trials of ketamine in the rapid treatment of major depressive episodes","volume":"45","author":"McGirr","year":"2015","journal-title":"Psychol. Med."},{"key":"10.1016\/j.pnpbp.2025.111533_bb0640","doi-asserted-by":"crossref","first-page":"75","DOI":"10.3389\/fnbeh.2020.00075","article-title":"Ketamine blocks morphine-induced conditioned place preference and anxiety-like behaviors in mice","volume":"14","author":"McKendrick","year":"2020","journal-title":"Front. Behav. Neurosci."},{"key":"10.1016\/j.pnpbp.2025.111533_bb0645","doi-asserted-by":"crossref","DOI":"10.1016\/j.addicn.2022.100025","article-title":"Classic and non-classic psychedelics for substance use disorder: A review of their historic, past and current research","volume":"3","author":"Mendes","year":"2022","journal-title":"Addict. Neurosci."},{"issue":"6","key":"10.1016\/j.pnpbp.2025.111533_bb0650","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1038\/s41591-021-01336-3","article-title":"MDMA-assisted therapy for severe PTSD: a randomized, double-blind, placebo-controlled phase 3 study","volume":"27","author":"Mitchell","year":"2021","journal-title":"Nat. Med."},{"issue":"4","key":"10.1016\/j.pnpbp.2025.111533_bb0655","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1177\/0269881110378371","article-title":"The safety and efficacy of {+\/\u2212}3,4-methylenedioxymethamphetamine-assisted psychotherapy in subjects with chronic, treatment-resistant posttraumatic stress disorder: the first randomized controlled pilot study","volume":"25","author":"Mithoefer","year":"2011","journal-title":"J. Psychopharmacol. (Oxford, England)"},{"issue":"1","key":"10.1016\/j.pnpbp.2025.111533_bb0660","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1177\/0269881112456611","article-title":"Durability of improvement in post-traumatic stress disorder symptoms and absence of harmful effects or drug dependency after 3,4-methylenedioxymethamphetamine-assisted psychotherapy: a prospective long-term follow-up study","volume":"27","author":"Mithoefer","year":"2013","journal-title":"J. Psychopharmacol. (Oxford, England)"},{"issue":"6","key":"10.1016\/j.pnpbp.2025.111533_bb0665","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/S2215-0366(18)30135-4","article-title":"3,4-methylenedioxymethamphetamine (MDMA)-assisted psychotherapy for post-traumatic stress disorder in military veterans, firefighters, and police officers: a randomised, double-blind, dose-response, phase 2 clinical trial","volume":"5","author":"Mithoefer","year":"2018","journal-title":"Lancet Psychiatry"},{"issue":"9","key":"10.1016\/j.pnpbp.2025.111533_bb0670","doi-asserted-by":"crossref","first-page":"2735","DOI":"10.1007\/s00213-019-05249-5","article-title":"MDMA-assisted psychotherapy for treatment of PTSD: study design and rationale for phase 3 trials based on pooled analysis of six phase 2 randomized controlled trials","volume":"236","author":"Mithoefer","year":"2019","journal-title":"Psychopharmacology"},{"issue":"11","key":"10.1016\/j.pnpbp.2025.111533_bb0675","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0241928","article-title":"Peripheral blood levels of brain-derived neurotrophic factor in patients with post-traumatic stress disorder (PTSD): A systematic review and meta-analysis","volume":"15","author":"Mojtabavi","year":"2020","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.pnpbp.2025.111533_bb0680","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1038\/s41593-023-01316-5","article-title":"Psychedelics promote plasticity by directly binding to BDNF receptor TrkB","volume":"26","author":"Moliner","year":"2023","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.pnpbp.2025.111533_bb0685","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.bbr.2017.04.052","article-title":"The involvement of brain-derived neurotrophic factor in 3,4-methylenedioxymethamphetamine-induced place preference and behavioral sensitization","volume":"329","author":"Mouri","year":"2017","journal-title":"Behav. Brain Res."},{"issue":"5","key":"10.1016\/j.pnpbp.2025.111533_bb0690","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1089\/adt.2016.747","article-title":"From psychiatry to flower power and Back again: the amazing story of lysergic acid diethylamide","volume":"14","author":"Mucke","year":"2016","journal-title":"Assay Drug Dev. Technol."},{"issue":"6","key":"10.1016\/j.pnpbp.2025.111533_bb0695","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1111\/acps.12818","article-title":"Increased thalamic resting-state connectivity as a core driver of LSD-induced hallucinations","volume":"136","author":"M\u00fcller","year":"2017","journal-title":"Acta Psychiatr. Scand."},{"issue":"4","key":"10.1016\/j.pnpbp.2025.111533_bb0700","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.biopsych.2012.06.022","article-title":"Rapid and longer-term antidepressant effects of repeated ketamine infusions in treatment-resistant major depression","volume":"74","author":"Murrough","year":"2013","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.pnpbp.2025.111533_bb0705","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2022.109356","article-title":"The effects of MDMA-assisted therapy on alcohol and substance use in a phase 3 trial for treatment of severe PTSD","volume":"233","author":"Nicholas","year":"2022","journal-title":"Drug Alcohol Depend."},{"issue":"2","key":"10.1016\/j.pnpbp.2025.111533_bb0710","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1124\/pr.115.011478","article-title":"Psychedelics","volume":"68","author":"Nichols","year":"2016","journal-title":"Pharmacol. Rev."},{"issue":"13","key":"10.1016\/j.pnpbp.2025.111533_bb0715","doi-asserted-by":"crossref","first-page":"2266","DOI":"10.1038\/s41386-021-01104-4","article-title":"Neuroimaging correlates and predictors of response to repeated-dose intravenous ketamine in PTSD: preliminary evidence","volume":"46","author":"Norbury","year":"2021","journal-title":"Neuropsychopharmacology"},{"issue":"1","key":"10.1016\/j.pnpbp.2025.111533_bb0720","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1177\/0269881112464827","article-title":"A randomized, controlled pilot study of MDMA (\u00b1 3,4-Methylenedioxymethamphetamine)-assisted psychotherapy for treatment of resistant, chronic post-traumatic stress disorder (PTSD)","volume":"27","author":"Oehen","year":"2013","journal-title":"J. Psychopharmacol. (Oxford, England)"},{"issue":"3","key":"10.1016\/j.pnpbp.2025.111533_bb0725","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1021\/acs.biochem.1c00812","article-title":"Biochemical mechanisms underlying psychedelic-induced neuroplasticity","volume":"61","author":"Olson","year":"2022","journal-title":"Biochemistry"},{"key":"10.1016\/j.pnpbp.2025.111533_bb0730","doi-asserted-by":"crossref","DOI":"10.1016\/j.ynstr.2022.100468","article-title":"Adjunct treatment with ketamine enhances the therapeutic effects of extinction learning after chronic unpredictable stress","volume":"19","author":"Paredes","year":"2022","journal-title":"Neurobiol. Stres"},{"issue":"1","key":"10.1016\/j.pnpbp.2025.111533_bb0735","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/nrn3379","article-title":"Neurotrophin regulation of neural circuit development and function","volume":"14","author":"Park","year":"2013","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.pnpbp.2025.111533_bb0740","first-page":"4","article-title":"The early use of MDMA (\u2018Ecstasy\u2019) in psychotherapy (1977\u20131985)","author":"Passie","year":"2018","journal-title":"Drug Sci., Policy Law"},{"issue":"4","key":"10.1016\/j.pnpbp.2025.111533_bb0745","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.1755-5949.2008.00059.x","article-title":"The pharmacology of lysergic acid diethylamide: a review","volume":"14","author":"Passie","year":"2008","journal-title":"CNS Neurosci. Ther."},{"issue":"9","key":"10.1016\/j.pnpbp.2025.111533_bb0750","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1001\/jama.2023.14530","article-title":"Single-dose psilocybin treatment for major depressive disorder: A randomized clinical trial","volume":"330","author":"Raison","year":"2023","journal-title":"JAMA"},{"issue":"9","key":"10.1016\/j.pnpbp.2025.111533_bb0755","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1016\/S0006-3223(99)00041-4","article-title":"Morphometric evidence for neuronal and glial prefrontal cell pathology in major depression","volume":"45","author":"Rajkowska","year":"1999","journal-title":"Biol. Psychiatry"},{"issue":"5","key":"10.1016\/j.pnpbp.2025.111533_bb0760","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1177\/0269881113478283","article-title":"Serial infusions of low-dose ketamine for major depression","volume":"27","author":"Rasmussen","year":"2013","journal-title":"J. Psychopharmacol. (Oxford, England)"},{"issue":"5","key":"10.1016\/j.pnpbp.2025.111533_bb0765","doi-asserted-by":"crossref","DOI":"10.1038\/tp.2014.26","article-title":"Decreased BDNF and TrkB mRNA expression in multiple cortical areas of patients with schizophrenia and mood disorders","volume":"4","author":"Ray","year":"2014","journal-title":"Transl. Psychiatry"},{"issue":"1","key":"10.1016\/j.pnpbp.2025.111533_bb0770","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/s00213-010-2121-3","article-title":"Chronic ketamine use increases serum levels of brain-derived neurotrophic factor","volume":"215","author":"Ricci","year":"2011","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pnpbp.2025.111533_bb0775","doi-asserted-by":"crossref","first-page":"974","DOI":"10.3389\/fphar.2017.00974","article-title":"Quality of the acute psychedelic experience predicts therapeutic efficacy of psilocybin for treatment-resistant depression","volume":"8","author":"Roseman","year":"2018","journal-title":"Front. Pharmacol."},{"issue":"1","key":"10.1016\/j.pnpbp.2025.111533_bb0780","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0163-7258(02)00234-6","article-title":"Therapeutic and adverse actions of serotonin transporter substrates","volume":"95","author":"Rothman","year":"2002","journal-title":"Pharmacol. Ther."},{"issue":"6","key":"10.1016\/j.pnpbp.2025.111533_bb0785","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1590\/1516-4446-2020-0884","article-title":"The pharmacological interaction of compounds in ayahuasca: a systematic review","volume":"42","author":"Ruffell","year":"2020","journal-title":"Revista brasileira de psiquiatria (Sao Paulo, Brazil\u202f: 1999)"},{"issue":"1","key":"10.1016\/j.pnpbp.2025.111533_bb0790","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1038\/s41398-022-02116-4","article-title":"The role of BDNF in mediating the prophylactic effects of (R,S)-ketamine on fear generalization and extinction","volume":"12","author":"Ryan","year":"2022","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.pnpbp.2025.111533_bb0795","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.bbr.2013.02.030","article-title":"mTOR activation is required for the anti-alcohol effect of ketamine, but not memantine, in alcohol-preferring rats","volume":"247","author":"Sabino","year":"2013","journal-title":"Behav. Brain Res."},{"issue":"4","key":"10.1016\/j.pnpbp.2025.111533_bb0800","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1001\/jamapsychiatry.2017.0080","article-title":"A consensus statement on the use of ketamine in the treatment of mood disorders","volume":"74","author":"Sanacora","year":"2017","journal-title":"JAMA Psychiatry"},{"issue":"7","key":"10.1016\/j.pnpbp.2025.111533_bb0805","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2019-230109","article-title":"First study of safety and tolerability of 3,4-methylenedioxymethamphetamine (MDMA)-assisted psychotherapy in patients with alcohol use disorder: preliminary data on the first four participants","volume":"12","author":"Sessa","year":"2019","journal-title":"BMJ Case Rep."},{"issue":"16","key":"10.1016\/j.pnpbp.2025.111533_bb0810","doi-asserted-by":"crossref","first-page":"2535","DOI":"10.1016\/j.neuron.2021.06.008","article-title":"Psilocybin induces rapid and persistent growth of dendritic spines in frontal cortex in vivo","volume":"109","author":"Shao","year":"2021","journal-title":"Neuron"},{"key":"10.1016\/j.pnpbp.2025.111533_bb0815","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/164_2018_113","article-title":"Pharmacology of MDMA- and amphetamine-like new psychoactive substances","volume":"252","author":"Simmler","year":"2018","journal-title":"Handb. Exp. Pharmacol."},{"issue":"8","key":"10.1016\/j.pnpbp.2025.111533_bb0820","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1176\/appi.ajp.2016.16010037","article-title":"A double-blind, randomized, placebo-controlled, dose-frequency study of intravenous ketamine in patients with treatment-resistant depression","volume":"173","author":"Singh","year":"2016","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.pnpbp.2025.111533_bb0825","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-1-4939-7571-6_1","article-title":"Neurotrophic factors: an overview","volume":"1727","author":"Skaper","year":"2018","journal-title":"Methods Mol. Biol. (Clifton, N.J.)"},{"issue":"4","key":"10.1016\/j.pnpbp.2025.111533_bb0830","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1002\/jcph.1995","article-title":"MDMA-assisted psychotherapy for treatment of posttraumatic stress disorder: A systematic review with Meta-analysis","volume":"62","author":"Smith","year":"2022","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.pnpbp.2025.111533_bb0835","doi-asserted-by":"crossref","first-page":"60","DOI":"10.14196\/mjiri.31.60","article-title":"The effect of 3,4- methylenedioxymethamphetamine on expression of neurotrophic factors in hippocampus of male rats","volume":"31","author":"Soleimani Asl","year":"2017","journal-title":"Med. J. Islam Repub. Iran"},{"issue":"2","key":"10.1016\/j.pnpbp.2025.111533_bb0840","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1111\/jcpt.12497","article-title":"What is the mechanism of ketamine\u2019s rapid-onset antidepressant effect? A concise overview of the surprisingly large number of possibilities","volume":"42","author":"Strasburger","year":"2017","journal-title":"J. Clin. Pharm. Ther."},{"issue":"2","key":"10.1016\/j.pnpbp.2025.111533_bb0850","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.mcn.2007.10.016","article-title":"The effects of exercise on spatial learning and anxiety-like behavior are mediated by an IGF-I-dependent mechanism related to hippocampal neurogenesis","volume":"37","author":"Trejo","year":"2008","journal-title":"Mol. Cell. Neurosci."},{"issue":"11","key":"10.1016\/j.pnpbp.2025.111533_bb0855","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1176\/appi.ajp.2012.12020248","article-title":"Brain-derived neurotrophic factor signaling and subgenual anterior cingulate cortex dysfunction in major depressive disorder","volume":"169","author":"Tripp","year":"2012","journal-title":"Am. J. Psychiatry"},{"issue":"1","key":"10.1016\/j.pnpbp.2025.111533_bb0860","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1176\/appi.ajp.163.1.28","article-title":"Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice","volume":"163","author":"Trivedi","year":"2006","journal-title":"Am. J. Psychiatry"},{"issue":"8","key":"10.1016\/j.pnpbp.2025.111533_bb0865","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.1523\/JNEUROSCI.17-08-02785.1997","article-title":"5-HT2A receptor-mediated regulation of brain-derived neurotrophic factor mRNA in the hippocampus and the neocortex","volume":"17","author":"Vaidya","year":"1997","journal-title":"J. Neurosci."},{"key":"10.1016\/j.pnpbp.2025.111533_bb0870","article-title":"Psychedelics and other psychoplastogens for treating mental illness","volume":"12","author":"Vargas","year":"2021","journal-title":"Front. Psychol."},{"issue":"11","key":"10.1016\/j.pnpbp.2025.111533_bb0875","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1111\/ejn.13572","article-title":"A single administration of the hallucinogen, 4-acetoxy-dimethyltryptamine, prevents the shift to a drug-dependent state and the expression of withdrawal aversions in rodents","volume":"45","author":"Vargas-Perez","year":"2017","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.pnpbp.2025.111533_bb0880","article-title":"Single-dose psilocybin-assisted therapy in major depressive disorder: A placebo-controlled, double-blind, randomised clinical trial","volume":"56","author":"von Rotz","year":"2022","journal-title":"EClinicalMedicine"},{"issue":"9","key":"10.1016\/j.pnpbp.2025.111533_bb0885","doi-asserted-by":"crossref","first-page":"3573","DOI":"10.1038\/s41380-023-02271-0","article-title":"Neuroimaging in psychedelic drug development: past, present, and future","volume":"28","author":"Wall","year":"2023","journal-title":"Mol. Psychiatry"},{"issue":"10","key":"10.1016\/j.pnpbp.2025.111533_bb0890","doi-asserted-by":"crossref","first-page":"2475","DOI":"10.1021\/acschemneuro.8b00294","article-title":"DARK classics in chemical neuroscience: Ibogaine","volume":"9","author":"Wasko","year":"2018","journal-title":"ACS Chem. Neurosci."},{"issue":"2","key":"10.1016\/j.pnpbp.2025.111533_bb0895","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1176\/appi.ajp.2017.17040472","article-title":"The effect of a single dose of intravenous ketamine on suicidal ideation: A systematic review and individual participant data Meta-analysis","volume":"175","author":"Wilkinson","year":"2018","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.pnpbp.2025.111533_bb0900","doi-asserted-by":"crossref","DOI":"10.1016\/j.pbb.2020.172927","article-title":"R-(\u2212)-ketamine modifies behavioral effects of morphine predicting efficacy as a novel therapy for opioid use disorder","volume":"194","author":"Witkin","year":"2020","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"9","key":"10.1016\/j.pnpbp.2025.111533_bb0905","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1080\/15622975.2019.1679391","article-title":"Ketamine-induced changes in plasma brain-derived neurotrophic factor (BDNF) levels are associated with the resting-state functional connectivity of the prefrontal cortex","volume":"21","author":"Woelfer","year":"2020","journal-title":"World J. Biol. Psychiatry"},{"issue":"11","key":"10.1016\/j.pnpbp.2025.111533_bb0910","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1016\/j.biopsych.2020.12.022","article-title":"Ketamine rapidly enhances glutamate-evoked dendritic Spinogenesis in medial prefrontal cortex through dopaminergic mechanisms","volume":"89","author":"Wu","year":"2021","journal-title":"Biol. Psychiatry"},{"issue":"1","key":"10.1016\/j.pnpbp.2025.111533_bb0915","doi-asserted-by":"crossref","first-page":"71","DOI":"10.3390\/biom14010071","article-title":"The role of the brain-derived neurotrophic factor in chronic pain: links to central sensitization and neuroinflammation","volume":"14","author":"Xiong","year":"2024","journal-title":"Biomolecules"},{"issue":"3","key":"10.1016\/j.pnpbp.2025.111533_bb0920","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1038\/s41380-021-01377-7","article-title":"Microglial ERK-NRBP1-CREB-BDNF signaling in sustained antidepressant actions of (R)-ketamine","volume":"27","author":"Yao","year":"2022","journal-title":"Mol. Psychiatry"},{"issue":"1","key":"10.1016\/j.pnpbp.2025.111533_bb0925","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s44192-022-00012-3","article-title":"Ketamine treatment for depression: a review","volume":"2","author":"Yavi","year":"2022","journal-title":"Discov. Ment. Health"},{"issue":"2","key":"10.1016\/j.pnpbp.2025.111533_bb0930","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1002\/cpt.565","article-title":"Potential psychiatric uses for MDMA","volume":"101","author":"Yazar-Klosinski","year":"2017","journal-title":"Clin. Pharmacol. Ther."},{"issue":"9","key":"10.1016\/j.pnpbp.2025.111533_bb0935","doi-asserted-by":"crossref","DOI":"10.1038\/tp.2015.138","article-title":"3,4-Methylenedioxymethamphetamine facilitates fear extinction learning","volume":"5","author":"Young","year":"2015","journal-title":"Transl. Psychiatry"},{"issue":"19","key":"10.1016\/j.pnpbp.2025.111533_bb0940","doi-asserted-by":"crossref","first-page":"2883","DOI":"10.1007\/s00213-017-4684-8","article-title":"Inhibition of serotonin transporters disrupts the enhancement of fear memory extinction by 3,4-methylenedioxymethamphetamine (MDMA)","volume":"234","author":"Young","year":"2017","journal-title":"Psychopharmacology"},{"issue":"3","key":"10.1016\/j.pnpbp.2025.111533_bb0945","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1097\/FBP.0b013e3282fe88a0","article-title":"Effects of scopolamine and ketamine on reconsolidation of morphine conditioned place preference in rats","volume":"19","author":"Zhai","year":"2008","journal-title":"Behav. Pharmacol."},{"issue":"1","key":"10.1016\/j.pnpbp.2025.111533_bb0950","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.pnpbp.2007.07.009","article-title":"AMPA receptor involvement in 5-hydroxytryptamine2A receptor-mediated pre-frontal cortical excitatory synaptic currents and DOI-induced head shakes","volume":"32","author":"Zhang","year":"2008","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"issue":"1","key":"10.1016\/j.pnpbp.2025.111533_bb0955","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1038\/mp.2012.180","article-title":"PTSD risk is associated with BDNF Val66Met and BDNF overexpression","volume":"19","author":"Zhang","year":"2014","journal-title":"Mol. Psychiatry"},{"issue":"4","key":"10.1016\/j.pnpbp.2025.111533_bb0960","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1007\/s00213-014-3697-9","article-title":"Anxiolytic effects of ketamine in animal models of posttraumatic stress disorder","volume":"232","author":"Zhang","year":"2015","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pnpbp.2025.111533_bb0965","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.jad.2021.02.058","article-title":"Effect of ketamine on mood dysfunction and spatial cognition deficits in PTSD mouse models via HCN1-BDNF signaling","volume":"286","author":"Zhang","year":"2021","journal-title":"J. Affect. Disord."}],"container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584625002878?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584625002878?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T14:16:16Z","timestamp":1762265776000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0278584625002878"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":191,"alternative-id":["S0278584625002878"],"URL":"https:\/\/doi.org\/10.1016\/j.pnpbp.2025.111533","relation":{},"ISSN":["0278-5846"],"issn-type":[{"value":"0278-5846","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Changing your mind: neuroplastic mechanisms underlying the therapeutic effect of psychedelics in depression, PTSD, and addiction","name":"articletitle","label":"Article Title"},{"value":"Progress in Neuro-Psychopharmacology and Biological Psychiatry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pnpbp.2025.111533","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"111533"}}